Thank you for stopping by!
Our participation at CPHI Worldwide 2025 in Frankfurt has come to an end, and we would like to warmly thank all visitors, partners, and professionals who stopped by Hall 5 – Booth 50A84 from 28 to 30 October.
It was three intense and inspiring days: meetings, exchanges of ideas, and new connections that confirmed how important it is to create moments of direct dialogue with those who live pharma innovation every day.
A special thank you to everyone who shared time and projects with us
Every conversation at the booth—from the first informal chat to more structured meetings—was a valuable opportunity to listen to real needs, discuss the industry’s challenges, and gather concrete insights for future developments.
Coming back from CPHI with so much energy (and so many new ideas) is the best sign of the value of these events.
The topics that sparked the most interest at our booth
During the exhibition we presented solutions designed to make products more effective, stable, and high-performing, with an approach focused on quality and validation. In particular, the most requested and discussed topics were:
-
Maximizing bioavailability: strategies and technologies to improve absorption and enhance the effectiveness of active ingredients.
-
Ingredient protection: systems designed to shield formulations from critical factors such as humidity, oxygen, and temperature, preserving their integrity over time.
-
Stability and shelf life: solutions to extend product lifespan while maintaining consistently high quality standards.
-
Improving solubility: targeted approaches for complex or poorly soluble ingredients, aiming for more functional formulations and optimized absorption.
-
Targeted and controlled release: technologies that modulate release, supporting effective action when and where it is needed.
Thank you for all the questions, feedback, and real-world cases you shared—these exchanges are exactly what makes innovation more concrete.
Medical devices, MDR, and our compliance pathway
At CPHI we also had the opportunity to update many visitors on our regulatory commitment: we work with a structured approach to ensure compliance, safety, and effectiveness, maintaining a quality system aligned with MDR requirements and carefully monitoring regulatory developments.
Clinical studies and validation: data that makes the difference
Another key topic was the value of scientific validation. We conduct clinical studies on supplements, cosmetics, and medical devices in compliance with European Regulation 2017/745 (MDR), collaborating with experts and qualified organizations to produce robust, reliable evidence.
New Cosmetics & Aesthetic Medicine Division
Among the most appreciated highlights, we enthusiastically presented the launch of our division dedicated to Cosmetics and Aesthetic Medicine, created to combine science, technology, and tradition into innovative solutions, with high standards of quality and safety.
The lines presented:
-
Armonita Laboratories – a professional line dedicated to aesthetic medicine doctors: fillers, peels, and advanced treatments designed for natural, reliable results.
-
Armonita Skincare – three collections inspired by authentic beauty and innovation:
-
Capri: radiance and regeneration, ideal for the first signs of aging
-
Tokyo: simplicity and technology for a minimalist, effective anti-aging approach
-
Milano: multitasking formulas for hydration and protection at any time of day
-
Want to learn more?
If you didn’t have the chance to visit our booth or would like to receive materials and further information about what we presented, we would be happy to hear from you.
We are a dietary supplements manufacturer and a partner for the production of medical devices, with an approach focused on quality, compliance, and innovation. Get in touch to schedule a meeting or request a call.
Thank you again for joining us—we look forward to seeing you at the next event!
